|
[1]REUBEN A, TILLMAN H, FONTANA RJ, et al.Outcomes in adults with acute liver failure between 1998 and 2013:An observational cohort study[J].Ann Intern Med, 2016, 164 (11) :724-732.
|
|
[2]ZAMORA R, VODOVOTZ Y, MI Q, et al.Data-driven modeling for precision medicine in pediatric acute liver failure[J].Mol Med, 2016.[Epub ahead of print]
|
|
[3]KORTM F, MARQUARDT I, ALAWI M, et al.Acute liver failure meets SOPH syndrome:A case report on an intermediate phenotype[J].Pediatrics, 2017, 139 (1) :e20160550.
|
|
[4]ASHLEY EA.The precision medicine initiative:A new national effort[J].JAMA, 2015, 313 (21) :2119-2120.
|
|
[5]CHUN M.Precision medicine initiative in the offing[J].Cancer Discov, 2015, 5 (5) :456.
|
|
[6]COLLINS FS, VARMUS H.A new initiative on precision medicine[J].N Engl J Med, 2015, 372 (9) :793-795.
|
|
[7]NIMMESGERN E, BENEDIKTSSON I, NORSTEDT I.Personalized medicine in Europe[J].Clin Transl Sci, 2017, 10 (2) :61-63.
|
|
[8]NARKEWICZ MR, DELL OD, KARPEN SJ, et al.Pattern of diagnostic evaluation for the causes of pediatric acute liver failure:An opportunity for quality improvement[J].J Pediatr, 2009, 155 (6) :801-806.e1.
|
|
[9]LEE WM.Recent developments in acute liver failure[J].Best Pract Res Clin Gastroenterol, 2012, 26 (1) :3-16.
|
|
[10]OKETANI M, IDO A, NAKAYAMA N, et al.Etiology and prognosis of fulminant hepatitis and late-onset hepatic failure in Japan:Summary of the annual nationwide survey between 2004 and 2009[J].Hepatol Res, 2013, 43 (2) :97-105.
|
|
[11]YOU S, RONG Y, ZHU B, et al.Changing etiology of liver failure in 3, 916 patients from northern China:A 10-year survey[J].Hepatol Int, 2013, 7 (2) :714-720.
|
|
[12]YAMAMOTO T, TAJIMA Y.HMGB1 is a promising therapeutic target for acute liver failure[J].Expert Rev Gastroenterol Hepatol, 2017, 11 (7) :673-682.
|
|
[13]European Association for the Study of the Liver.EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis[J].J Hepatol, 2018.[Epub ahead of print]
|
|
[14]BERNAL W, WENDON J.Acute liver failure[J].N Engl J Med, 2013, 369 (26) :2525-2534.
|
|
[15]FAGAN EA.Acute liver failure of unknown pathogenesis:the hidden agenda[J].Hepatology, 1994, 19 (5) :1307-1312.
|
|
[16]STEPHENS MC, BOARDMAN LA, LAZARIDIS KN.Individualized medicine in gastroenterology and hepatology[J].Mayo Clin Proc, 2017, 92 (5) :810-825.
|
|
[17]FIX OK, LIOU I, KARVELLAS CJ, et al.Development and pilot of a checklist for management of acute liver failure in the intensive care unit[J].PLo S One, 2016, 11 (5) :e0155500.
|
|
[18]LEE WM, BROWN KE, YOUNG NS, et al.Brief report:No evidence for parvovirus B19 or hepatitis E virus as a cause of acute liver failure[J].Dig Dis Sci, 2006, 51 (10) :1712-1715.
|
|
[19]LEVITSKY J, DUDDEMPUDI AT, LAKEMAN FD, et al.Detection and diagnosis of herpes simplex virus infection in adults with acute liver failure[J].Liver Transpl, 2008, 14 (10) :1498-1504.
|
|
[20]MELLINGER JL, ROSSARO L, NAUGLER WE, et al.Epstein-Barr virus (EBV) related acute liver failure:A case series from the US A-cute Liver Failure Study Group[J].Dig Dis Sci, 2014, 59 (7) :1630-1637.
|
|
[21]STRAVITZ RT, KRAMER DJ.Management of acute liver failure[J].Nat Rev Gastroenterol Hepatol, 2009, 6 (9) :542-53.
|
|
[22]SOMASEKAR S, LEE D, RULE J, et al.Viral surveillance in serum samples from patients with acute liver failure by metagenomic next-generation sequencing[J].Clin Infect Dis, 2017, 65 (9) :1477-1485.
|
|
[23]LARSON AM, POLSON J, FONTANA RJ, et al.Acetaminophen-induced acute liver failure:Results of a United States multicenter, prospective study[J].Hepatology, 2005, 42 (6) :1364-1372.
|
|
[24]OSTAPOWICZ G, FONTANA RJ, SCHIDT FV, et al.Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States[J].Ann Intern Med, 2002, 137 (12) :947-954.
|
|
[25]FUJIWARA K, YASUI S, NAKANO M, et al.Severe and fulminant hepatitis of indeterminate etiology in a Japanese center[J].Hepatol Res, 2015, 45 (10) :e141-149.
|
|
[26]ALONSO EM, JAMES LP, ZHANG S, et al.Acetaminophen adducts detected in serum of pediatric patients with acute liver failure[J].J Pediatr Gastroenterol Nutr, 2015, 61 (1) :102-107.
|
|
[27]DAVERN TJ, JAMES LP, HINSON JA, et al.Measurement of serum acetaminophen-protein adducts in patients with acute liver failure[J].Gastroenterology, 2006, 130 (3) :687-694.
|
|
[28]WENDON J, CORDOBA J, DHAWAN A, et al.EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure[J].J Hepatol, 2017, 66 (5) :1047-1081.
|
|
[29]HEGARTY R, HADZIC N, GISSEN P, et al.Inherited metabolic disorders presenting as acute liver failure in newborns and young children:King's College Hospital experience[J].Eur J Pediatr, 2015, 174 (10) :1387-1392.
|
|
[30]STAUFNER C, HAACK TB, KPKE MG, et al.Recurrent acute liver failure due to NBAS deficiency:Phenotypic spectrum, disease mechanisms, and therapeutic concepts[J].J Inherit Metab Dis, 2016, 39 (1) :3-16.
|
|
[31]BERNSMEIER C, ANTONIADES CG, WENDON J.What's new in acute liver failure[J].Intensive Care Med, 2014, 40 (10) :1545-1548.
|
|
[32]MAHFOUDH BA, SELMI R, BEJAOUI M, et al.Effectiveness of a single versus repeated administration of trimetazidine in the protection against warm ischemia/reperfusion injury of rat liver[J].Turk J Med Sci, 2016, 46 (4) :1258-1264.
|
|
[33]CHEN H, SHEN ZY, XU W, et al.Expression of P450 and nuclear receptors in normal and end-stage Chinese livers[J].World JGastroenterol, 2014, 20 (26) :8681-8690.
|
|
[34]PENG WX, REN QX, LI X, et al.Role of blood concentration monitoring on voriconazole therapy for patients with liver failure[J].China Pharmacy, 2016, 27 (2) :267-268. (in Chinese) 彭文绣, 任秋霞, 李璇, 等.血药浓度监测在肝衰竭患者应用伏立康唑治疗肺部感染中的作用[J].中国药房, 2016, 27 (2) :267-268.
|
|
[35]TAN K, BRAYSHAW N, TOMASZEWSKI K, et al.Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities[J].J Clin Pharmacol, 2006, 46 (2) :235-243.
|
|
[36]ROUTY B, LE CE, DEROSA L, et al.Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors[J].Science, 2018, 359 (6371) :91-97.
|
|
[37]SHI M, ZHANG Z, XU R, et al.Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients[J].Stem Cells Transl Med, 2012, 1 (10) :725-731.
|
|
[38]LIN BL, CHEN JF, QIU WH, et al.Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure:A randomized controlled trial[J].Hepatology, 2017, 66 (1) :209-219.
|
DownLoad: